Debate. Revascularization of nonculprit lesions in ACS: physiology or OCT-guided or both? Perspective from imaging

QUESTION: What is the benefit of intravascular imaging modalities—specifically the optical coherence tomography (OCT)—in the context of nonculprit lesions of an acute coronary syndrome (ACS)? ANSWER: The publications of the COMPLETE and FLOWER MI clinical trials has changed the...

Full description

Bibliographic Details
Main Author: Josep Gómez-Lara
Format: Article
Language:English
Published: Permanyer 2023-05-01
Series:REC: Interventional Cardiology (English Ed.)
Online Access:https://recintervcardiol.org/en/index.php?option=com_content&view=article&id=1069
_version_ 1797829843605258240
author Josep Gómez-Lara
author_facet Josep Gómez-Lara
author_sort Josep Gómez-Lara
collection DOAJ
description QUESTION: What is the benefit of intravascular imaging modalities—specifically the optical coherence tomography (OCT)—in the context of nonculprit lesions of an acute coronary syndrome (ACS)? ANSWER: The publications of the COMPLETE and FLOWER MI clinical trials has changed the management of nonculprit lesions tremendously in patients with ACS jeopardizing the role of the pressure guidewire guiding the revascularization of these lesions.1,2 In the COMPLETE trial, angiography-guided complete revascularization reduced the rates of death and infarction compared to the optimal medical therapy (OMT).1 We should mention that over 80% of the lesions included had an angiographic percent diameter stenosis ≥ 70%.1 In the FLOWER MI trial that included less severe nonculprit lesions, pressure guidewire-guided complete revascularization reduced the number of lesions treated (45% fewer lesions) compared to angiography-guided complete revascularization with a similar rate of events in both strategies.2 However, a subanalysis of the group of patients treated with pressure guidewire guidance revealed that patients with fractional flow reserve (FFR) values ≤ 0.80 (stented according to protocol) had fewer events compared to patients with FFR values > 0.80 (treated with OMT).3 This has aroused controversy regarding the utility of the pressure guidewire in this context. Probably the reason why the FFR has...
first_indexed 2024-04-09T13:27:33Z
format Article
id doaj.art-8af729c76de94580a9a8358754d37265
institution Directory Open Access Journal
issn 2604-7322
language English
last_indexed 2024-04-09T13:27:33Z
publishDate 2023-05-01
publisher Permanyer
record_format Article
series REC: Interventional Cardiology (English Ed.)
spelling doaj.art-8af729c76de94580a9a8358754d372652023-05-10T06:59:27ZengPermanyerREC: Interventional Cardiology (English Ed.)2604-73222023-05-015213914110.24875/RECICE.M23000365Debate. Revascularization of nonculprit lesions in ACS: physiology or OCT-guided or both? Perspective from imagingJosep Gómez-Lara0Servicio de Cardiología, Hospital Universitari de Bellvitge, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Universitat de Barcelona, L'Hospitalet de Llobregat, Barcelona, SpainQUESTION: What is the benefit of intravascular imaging modalities—specifically the optical coherence tomography (OCT)—in the context of nonculprit lesions of an acute coronary syndrome (ACS)? ANSWER: The publications of the COMPLETE and FLOWER MI clinical trials has changed the management of nonculprit lesions tremendously in patients with ACS jeopardizing the role of the pressure guidewire guiding the revascularization of these lesions.1,2 In the COMPLETE trial, angiography-guided complete revascularization reduced the rates of death and infarction compared to the optimal medical therapy (OMT).1 We should mention that over 80% of the lesions included had an angiographic percent diameter stenosis ≥ 70%.1 In the FLOWER MI trial that included less severe nonculprit lesions, pressure guidewire-guided complete revascularization reduced the number of lesions treated (45% fewer lesions) compared to angiography-guided complete revascularization with a similar rate of events in both strategies.2 However, a subanalysis of the group of patients treated with pressure guidewire guidance revealed that patients with fractional flow reserve (FFR) values ≤ 0.80 (stented according to protocol) had fewer events compared to patients with FFR values > 0.80 (treated with OMT).3 This has aroused controversy regarding the utility of the pressure guidewire in this context. Probably the reason why the FFR has...https://recintervcardiol.org/en/index.php?option=com_content&view=article&id=1069
spellingShingle Josep Gómez-Lara
Debate. Revascularization of nonculprit lesions in ACS: physiology or OCT-guided or both? Perspective from imaging
REC: Interventional Cardiology (English Ed.)
title Debate. Revascularization of nonculprit lesions in ACS: physiology or OCT-guided or both? Perspective from imaging
title_full Debate. Revascularization of nonculprit lesions in ACS: physiology or OCT-guided or both? Perspective from imaging
title_fullStr Debate. Revascularization of nonculprit lesions in ACS: physiology or OCT-guided or both? Perspective from imaging
title_full_unstemmed Debate. Revascularization of nonculprit lesions in ACS: physiology or OCT-guided or both? Perspective from imaging
title_short Debate. Revascularization of nonculprit lesions in ACS: physiology or OCT-guided or both? Perspective from imaging
title_sort debate revascularization of nonculprit lesions in acs physiology or oct guided or both perspective from imaging
url https://recintervcardiol.org/en/index.php?option=com_content&view=article&id=1069
work_keys_str_mv AT josepgomezlara debaterevascularizationofnonculpritlesionsinacsphysiologyoroctguidedorbothperspectivefromimaging